Pfizer, U.S. ink $5.29B deal for COVID pill

NEW YORK (AP) — The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if regulators approve it. Pfizer asked U.S. regulators on Tuesday to authorize the experimental pill, which has been shown to significantly cut the rate of hospitalizations and deaths among people with coronavirus [...]